Scrip World Pharmaceutical News - Research & Development News
 
Scrip World Pharmaceutical News - Home

Latest Research & Development News

Aurobindo receives final FDA OK for stavudine

Tuesday 6 January 2009

GTx files toremifene in US for bone fractures

Tuesday 6 January 2009

Strides gets FDA OK for sterile vancomycin

Tuesday 6 January 2009

US panel to review Lilly/Daiichi's prasugrel in February

Tuesday 6 January 2009

FDA user fee date for King's Embeda passes without action
The US FDA's review of King Pharmaceuticals' (formerly Alpharma's) Embeda, a modified-released formulation of morphine coupled with the opioid antagonist naltrexone, has been extended beyond the late December user fee date.
Tuesday 6 January 2009

Serbia to participate in Phase III NSCLC vaccine trial

Monday 5 January 2009

Takeda's antidiabetic alogliptin hits another US delay

Monday 5 January 2009

US approval of Ipsen's Dysport awaits final REMS

Monday 5 January 2009

US FDA accepts Savient's pegloticase BLA for priority review

Monday 5 January 2009

US says more data needed for Salix's colitis drug

Monday 5 January 2009

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 Next

Email to a friend

Most Read Articles

About Scrip

Scrip World Pharmaceutical News provides you with high quality news coverage of pharma and biotech and also gives you strategic data and analysis.

Subscribe to Scrip World Pharmaceutical News today!Benefits include:

›› Daily email headlines

›› Searchable news
archive

›› Weekly copies of Scrip

›› Bespoke Scrip supplements

›› Plus the Scrip Yearbook
and Scrip League Tables

FREE TRIAL
SUBSCRIBE

Scrip Awards 2008

The best and brightest of the pharmaceutical and biotech industries were celebrated at a glittering ceremony in London at the 2008 Scrip Awards.

Read the full story

Scrip Directory

Scrip Directory 2008

Search over 20,000 international contacts and access potential business opportunities